Pain News and Research

Latest Pain News and Research

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

A popular surgery to repair meniscal tears may increase the risk of osteoarthritis and cartilage loss in some patients, according to research presented today at the annual meeting of the Radiological Society of North America. The findings show that the decision for surgery requires careful consideration in order to avoid accelerated disease onset, researchers said.

3 Dec 2014

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD).

2 Dec 2014

AcelRx Pharmaceuticals' Zalviso device gets CE Mark approval

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.

2 Dec 2014

Identifying infant and toddler injuries that require emergency medical care

Bianca Edison, MD, MS is an attending physician in the Children's Orthopaedic Center at Children's Hospital Los Angeles, and is assistant clinical professor of Orthopaedics at the Keck School of Medicine of the University of Southern California. Edison is a licensed, Board-Certified pediatrician and Fellow of the American Academy of Pediatrics who completed a fellowship in Primary Care SportsMedicine. Her interests and experience include orthopaedic conditions affecting young children, teens, and athletes. Here she reviews common infant and toddler injuries, and how parents can determine if emergency medical care is needed.

2 Dec 2014

Young adults who skip college are at higher risk for nonmedical prescription opioid use

A study just released by Columbia University's Mailman School of Public Health compared the use of prescription opioids and stimulants among high school graduates, non-graduates, and their college-attending peers, and found that young adults who do not attend college are at particularly high risk for nonmedical prescription opioid use and disorder.

2 Dec 2014

Orthopedic surgeons recommend prompt medical attention for shoulder dislocations

Prompt and appropriate treatment of a dislocated shoulder--when the head of the upper arm bone (humerus) is completely knocked out of the shoulder socket (glenoid)--can minimize risk for future dislocations as well as the effects of related bone, muscle and nerve injuries, according to a literature review appearing in the December issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

2 Dec 2014

New approach can prevent chronic marijuana use, relieve mood, anxiety disorders

Replenishing the supply of a molecule that normally activates cannabinoid receptors in the brain could relieve mood and anxiety disorders and enable some people to quit using marijuana, a Vanderbilt University study suggests.

2 Dec 2014

Pain medicine specialist receives award for new advances in oral fluid testing

This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.

2 Dec 2014

Eylea receives Health Canada approval for treatment of CRVO and DME

Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

1 Dec 2014

Cepheid gets FDA clearance to market Xpert Norovirus

Cepheid today announced it has received clearance from the U.S. Food & Drug Administration to market Xpert Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII).

1 Dec 2014

Australian Prescriber publishes top 10 subsidised drugs in Australia

The annual publication of the top 10 subsidised drugs appears in the December edition of Australian Prescriber. Statins (cholesterol-lowering medicines) top the lists again.

1 Dec 2014

EMA accepts new IMBRUVICA (ibrutinib) application for treatment of Waldenstrom's macroglobulinemia

Pharmacyclics, Inc.today announced the acceptance of a Type II variation application for IMBRUVICA (ibrutinib) by the European Medicines Agency.

1 Dec 2014

Kessler Institute provides tips to help reduce risk of injury during winter months

Winter appears to have arrived early, bringing with it record snowfalls and cold temperatures across the country. It also brings an increased risk for injuries. Whether shoveling snow, dealing with icy roads, or simply trying to walk on wet, slippery pavement, caution is the key word.

29 Nov 2014

Lord Saatchi's Medical Innovation Bill may cause serious harm to patients

The Medical Innovation Bill tabled by Lord Saatchi and currently making its way through the UK’s House of Lords “strikes at the heart of evidence-based medicine” and risks “opening the door to the use of less proven, or unproven, approaches such as complementary or alternative medicine”, according to a new Editorial published in The Lancet Oncology.

29 Nov 2014

Researchers discover molecular switch that triggers stress processes in the brain

At the Center for Brain Research at the MedUni Vienna an important factor for stress has been identified in collaboration with the Karolinska Institutet in Stockholm (Sweden). This is the protein secretagogin that plays an important role in the release of the stress hormone CRH and which only then enables stress processes in the brain to be transmitted to the pituitary gland and then onwards to the organs.

28 Nov 2014

New guideline now available to help prevent, treat delirium in older patients

A new guideline is available to help health care providers prevent and treat one of the most common postoperative complications in older patients, delirium, which is an episode of sudden confusion.

27 Nov 2014

Immune Pharmaceuticals closes underwriter's exercise of partial over-allotment option of 459,697 units

Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today completed the underwriter's exercise of partial over-allotment option of 459,697 units, at a price of $2.50 per unit, for gross proceeds of approximately $1.06 million, bringing the aggregate gross proceeds of the Company's previously announced underwritten public offering to $9.685 million.

27 Nov 2014

Current evidence does not support routine minimally invasive disc surgery, say researchers

McMaster University researchers have found that current evidence does not support the routine use of minimally invasive surgery to remove herniated disc material pressing on the nerve root or spinal cord in the neck or lower back.

27 Nov 2014

Higher surge of testosterone in competition not tied to winning, shows study

A higher surge of testosterone in competition, the so-called "winner effect," is not actually related to winning, suggests a new study of intercollegiate cross country runners.

27 Nov 2014

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

MEDICAL technology designers are to pitch a new contoured support snood helping to improve the quality of lives of motor neurone disease sufferers whose neck muscles have weakened to a panel of Dragons’ Den style judges as part of a £10,000 innovation challenge.

27 Nov 2014

Pain News and Research

Latest Pain News and Research

Meniscal surgery may increase risk of osteoarthritis, cartilage loss

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

AcelRx Pharmaceuticals' Zalviso device gets CE Mark approval

Identifying infant and toddler injuries that require emergency medical care

Young adults who skip college are at higher risk for nonmedical prescription opioid use

Orthopedic surgeons recommend prompt medical attention for shoulder dislocations

New approach can prevent chronic marijuana use, relieve mood, anxiety disorders

Pain medicine specialist receives award for new advances in oral fluid testing

Eylea receives Health Canada approval for treatment of CRVO and DME

Cepheid gets FDA clearance to market Xpert Norovirus

Australian Prescriber publishes top 10 subsidised drugs in Australia

EMA accepts new IMBRUVICA (ibrutinib) application for treatment of Waldenstrom's macroglobulinemia

Kessler Institute provides tips to help reduce risk of injury during winter months

Lord Saatchi's Medical Innovation Bill may cause serious harm to patients

Researchers discover molecular switch that triggers stress processes in the brain

New guideline now available to help prevent, treat delirium in older patients

Immune Pharmaceuticals closes underwriter's exercise of partial over-allotment option of 459,697 units

Current evidence does not support routine minimally invasive disc surgery, say researchers

Higher surge of testosterone in competition not tied to winning, shows study

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

Forensics and toxicology - Industry Focus eBook eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

Forensics and toxicology - Industry Focus eBook eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in